According to the short activity, it could be earlier than the 29th of June because the number of shorts came down from 86K to 35K in 2 weeks ( end of April to 15th of May). On the other hand by the end of June 3 patients (?) will complete the study and IMO over 10 of them have past 6-month follow-up points. Of course, ATH can publish the 6-month results when there are enough cases and the 1-year results much later. These results are important for the market cap, but even more important for MC is that Big Pharma will be interested in ATH434 or that M Fox will give more money for the PD study. These can happen next week or next September, November or December. Interesting times.
Why deferiprone did not work in PD, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.631K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 81072032 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 2447647 | 3 |
View Market Depth
| Last trade - 15.59pm 18/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |